30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Current & Critical

Entry Into Joint Replacement a Major Step in Globus Medical’s Evolution

In October, we sat down with leaders from Globus Medical to discuss their surprising entrance into the joint replacement market and robotics’ role in orthopedic surgery. As a quick refresher, during 2Q19 Globus Medical announced that it had acquired substantially all of the assets of StelKast, a privately-held manufacturer of knee and hip replacement implants and instruments. Globus paid USD $24.1 million in cash upfront with an additional potential $4.3 million in product milestone payments. Globus is expected to commercialize a robotic system for joint replacement in late 2020.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.